Suppr超能文献

[2005年肾脏流行病学与信息网络及生物医学局年度报告]

[REIN annual report 2005. Renal Epidemiology and Information Network & Agence de la biomédecine].

作者信息

Couchoud Cécile, Stengel Bénédicte, Jacquelinet Christian

机构信息

Agence de la biomédecine, Coordination nationale rein, Saint-denis-la-plaine cedex, France.

出版信息

Nephrol Ther. 2007 Apr;3 Suppl 1:S1-82.

Abstract

In 2005, 6,021 patients with end-stage renal disease living in fourteen regions covering 45 millions inhabitants (73% of the French population), started renal replacement therapy (dialysis or preemptive graft): median age was 70 years; 3% had a preemptive graft. The overall crude annual incidence rate of renal replacement therapy for end-stage renal disease was 139 per million population (pmp) in thirteen regions that met exhaustivity, with significant differences in sex and age-adjusted incidence across regions (92 to 171 pmh). At initiation, 48% of the patients had at least one cardiovascular disease and 36% diabetes (89% Type 2 non-insulin-dependent diabetes). On December 31, 2005, 21,813 patients living in these fourteen regions were on dialysis: median age was 69 years. The overall crude prevalence rate of dialysis was 539 pmp in thirteen regions. On December 31, 2005, 19,491 patients were living with a functioning graft : median age was 53 years. The overall crude prevalence rate for these patients was 390 pmp in thirteen regions. The overall crude prevalence rate of renal replacement therapy for end-stage renal disease was 929 pmp in thirteen regions, with significant differences in age-adjusted prevalence across regions (732 to 1009 pmh). In the 2002-05 cohort of 11,632 incident patients, the overall one-year survival rate was 82%, 72% at 2 years and 62% at 3 years. Survival decreased with age, but remained above 50% at 2 years in patients older than 75 at RRT initiation. Among the 5,902 new patients starting dialysis in 2005 in the 14 regions, 7% had a BMI lower than 18,5 kg/m2 and 16% a BMI higher than 30. At initiation, 63% had an haemoglobin value lower than 11 g/ l and 9% an albumin value lower than 25 g/l. The first haemodialysis was started in emergency in 30% of the patients and with a catheter in 46%. On December 31, 2005, 8% treated in the dialysis units of the fourteen regions received peritoneal dialysis, of which 35% were treated with automated peritoneal dialysis. 94% of the patients on haemodialysis had 3 sessions per week, with a median duration of 4 hours. In 2005, 1,911 patients received a renal graft. On December 31, 2005, 4,634 patients were on the waiting List for a renal graft in the transplantation centres of the 14 regions.

摘要

2005年,居住在覆盖4500万居民(占法国人口的73%)的14个地区的6021例终末期肾病患者开始接受肾脏替代治疗(透析或择期移植):中位年龄为70岁;3%接受了择期移植。在13个数据完整的地区,终末期肾病肾脏替代治疗的总体粗年发病率为每百万人口139例(pmp),各地区经性别和年龄调整后的发病率存在显著差异(92至171例/百万人口)。开始治疗时,48%的患者至少患有一种心血管疾病,36%患有糖尿病(89%为2型非胰岛素依赖型糖尿病)。2005年12月31日,居住在这14个地区的21813例患者正在接受透析:中位年龄为69岁。13个地区透析的总体粗患病率为539例/百万人口。2005年12月31日,19491例患者接受了有功能的移植:中位年龄为53岁。这部分患者在13个地区的总体粗患病率为390例/百万人口。13个地区终末期肾病肾脏替代治疗的总体粗患病率为929例/百万人口,各地区经年龄调整后的患病率存在显著差异(732至1009例/百万人口)。在2002 - 2005年队列中的11632例新发病患者中,总体1年生存率为82%,2年生存率为72%,3年生存率为62%。生存率随年龄下降,但在开始肾脏替代治疗时年龄超过75岁的患者中,2年生存率仍高于50%。2005年在这14个地区开始透析的5902例新患者中,7%的体重指数(BMI)低于18.5 kg/m²,16%的BMI高于30。开始治疗时,63%的患者血红蛋白值低于11 g/l,9%的患者白蛋白值低于25 g/l。30%的患者首次血液透析是在紧急情况下开始进行的,46%的患者使用了导管。2005年12月31日,在这14个地区透析单位接受治疗的患者中,8%接受腹膜透析,其中35%接受自动腹膜透析。94%接受血液透析的患者每周进行3次治疗,每次治疗中位时长为4小时。2005年,1911例患者接受了肾脏移植。2005年12月31日,在这14个地区的移植中心,有4634例患者在等待肾脏移植。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验